“…The visual analysis of docked complexes revealed that the Dicaffeoylquinic acid displayed maximum number of hydrogen bond with the residues responsible for significant role in binding. Previously published studies reported that the residues Lys417, Phe456, Gln493, Glu484, Tyr473, and Tyr489 of S-RBD interface majorly contributed in binding with ACE2 [ 7 , 9 , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] ]. Moreover, in various in-silico studies, many phytochemicals (Bis-demethoxycurcumin, compound-4, compound-2, hesperidin, emodin, chrysin, nabiximols, pectolinarin, epigallocatechin gallate, rhoifolin, andrographolide, artemisinin, apigenin, berberine, emodin, capsaicin, glabridin, colchicine, harmaline, kaempferol, harmine, niranthin, phyllanthin, oleic acid, rosavin, withanolide A, withaferin A, curcumin, apigenin, and chrysophanol) were also recommended as S-RBD inhibitors on the basis of molecular docking studies [ [53] , [54] , [55] , [56] ].…”